More research is needed to determine if the reported improvements in the reproductive parameters are directly related to the GLP1-RA or are due to weight loss, or both
There is a need for a multi-level approach that considers not only individual decisions but also environmental, economic, and cultural determinants of reproductive health [22, 23]
Key criteria from Cigna's GLP-1 Coverage Policy: [5] BMI (body mass index) 30 (or 27 with hypertension, type 2 diabetes, sleep apnea, cardiovascular disease) 3 months documented lifestyle efforts (diet and exercise in your medical record) No concurrent GLP-1 use can't take Wegovy with Ozempic or other GLP-1 medications Renewal: Must lose 5% of starting weight to continue coverage Cigna Decision Timelines For medical services (not prescriptions), standard reviews take 5-7 business days
Clinical studies show that the combination therapy of semaglutide and metformin is more effective than using each medication alone
Both agents demonstrated favorable effects on liver enzyme levels and lipid profiles